Skip to main content

Advertisement

SpringerLink
Log in

Potentially inappropriate medications in the elderly: a comprehensive protocol

  • Review Article
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Elderly patients are at increased risk of drug-related morbidity and mortality. Avoiding the use of potentially inappropriate medications (PIMs) is one of the strategies that has been widely adopted to reduce the harmful consequences of drug use. There are several PIM screening tools available. In this review, we provide an overview of existing screening tools to detect PIMs in the elderly, emphasizing the advantages and disadvantages of each. Combining previously published and adopted tools (adjusted Beers list, French consensus panel, McLeod’s list, and Lindblad’s list of clinically important drug–disease interactions), we develop a new comprehensive tool that also includes the adjusted Hanlon’s and Malone’s lists of potentially serious drug–drug interactions in the elderly. In addition to listed PIMs and clinically important drug–drug interactions, alternative therapeutic solutions are suggested. The new protocol differentiates: drugs with an unfavorable benefit/risk ratio (to be avoided regardless of the underlying disease/condition), drugs with a questionable efficacy, and drugs to be avoided with certain diseases/conditions, and provides a list of potentially serious drug–drug interactions. A tool consisting of PIMs and potential drug–drug interactions within the same protocol provides more comprehensive quality assessment of drug-prescribing behavior to the elderly, which in turn may lead to better prescribing practices.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. United Nations Population Division. World Population Ageing: 1950–2050. Available at:http://www.un.org/esa/population/publications/worldageing19502050/. Accessed 1 Oct 2011

  2. Gallagher P, Barry P, O’Mahony D (2007) Inappropriate prescribing in the elderly. J Clin Pharm Ther 32(2):113–121

    Article  PubMed  CAS  Google Scholar 

  3. Routledge PA, O’Mahony MS, Woodhouse KW (2004) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57(2):121–126

    Article  PubMed  CAS  Google Scholar 

  4. Hamilton HJ, Gallagher PF, O’Mahony D (2009) Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 9:5

    Article  PubMed  Google Scholar 

  5. Laroche ML, Charmes JP, Bouthier F, Merle L (2009) Inappropriate medications in the elderly. Clin Pharmacol Ther 85(1):94–97

    Article  PubMed  CAS  Google Scholar 

  6. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determinig inappropriate medication use in nursing home residents. Arch Intern Med 151:1825–1832

    Article  PubMed  CAS  Google Scholar 

  7. Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 57(14):1531–1536

    Article  Google Scholar 

  8. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC (1997) Defining inappropriate practice in prescribing for elderly people: a national consensus panel. Can Med Assoc J 156(3):385–391

    CAS  Google Scholar 

  9. Naugler CT, Brymer C, Stolee P, Arcese ZA (2000) Development and validation of an improved prescribing in the elderly tool. Can J Clin Pharmacol 7:103–107

    PubMed  CAS  Google Scholar 

  10. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria. Arch Intern Med 63(22):2716–2724

    Article  Google Scholar 

  11. Lindblad CI, Hanlon JT, Gross CR, Sloane RJ, Pieper CF, Hajjar ER et al (2006) Clinically important drug–disease interactions and their prevalence in older adults. Consensus statement. Clin Ther 28(8):1133–1143

    Article  PubMed  CAS  Google Scholar 

  12. Laroche ML, Charmes JP, Merie L (2007) Potentially inappropriate medications in the elderly. A French consensus panel list. Eur J Clin Pharmacol 63(8):725–731

    Article  PubMed  Google Scholar 

  13. Barry PJ, Gallagher P, Ryan C, O’Mahony D (2007) START (screening tool to alert doctors to the right treatment)—an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 36(6):632–638

    Article  PubMed  CAS  Google Scholar 

  14. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D (2008) STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharm Ther 46(2):72–83

    CAS  Google Scholar 

  15. Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J (2009) The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 27(3):153–159

    Article  PubMed  Google Scholar 

  16. Holt S, Schmiedl S, Thürmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arzteblatt Int 107(31–32):543–551

    Google Scholar 

  17. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK et al (1992) A method for assessing drug therapy appropriateness. J Clin Epidemiol 45(10):1045–1051

    Article  PubMed  CAS  Google Scholar 

  18. Page RL 2nd, Linnebur SA, Bryant LL, Ruscin JM (2010) Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 5:75–87

    Article  PubMed  CAS  Google Scholar 

  19. Levy HB, Marcus EL, Christen C (2010) Beyond the beers criteria: a comparative overview of explicit criteria. Ann Pharmacother 44(12):1968–1975

    Article  PubMed  Google Scholar 

  20. Gallagher P, O’Mahony D (2008) STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 37(6):673–679

    Article  PubMed  Google Scholar 

  21. Pitkala KH, Strandberg TE, Tilvis RS (2002) Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. Arch Intern Med 162(15):1707–1712

    Article  PubMed  Google Scholar 

  22. Onder G, Landi F, Cesari M, Gambassi G, Carbonin P, Bernabei R, Investigators of the GIFA Study (2003) Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol 59(2):157–162

    PubMed  Google Scholar 

  23. van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, van der Cammen TJ, Stricker BH et al (2005) Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria–a population-based cohort study. Br J Clin Pharmacol 60(2):137–144

    Article  PubMed  Google Scholar 

  24. Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, AdHOC Project Research Group et al (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293(11):1348–1358

    Article  PubMed  Google Scholar 

  25. Bonk ME, Krown H, Matuszewski K, Oinonen M (2006) Potentially inappropriate medications in hospitalized senior patients. Am J Health Syst Pharm 63(12):1161–1165

    Article  PubMed  Google Scholar 

  26. Barry PJ, O’Keefe N, O’Connor KA, O’Mahony D (2006) Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 31(6):617–626

    Article  PubMed  CAS  Google Scholar 

  27. Fick DM, Waller JL, Maclean JR et al (2001) Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilization. J Manag Care Pharm 7(5):407–413

    Google Scholar 

  28. Fu AZ, Liu GG, Christensen DB (2004) Inappropriate medication use and health outcomes in the elderly. J Am Geriatr Soc 52(11):1934–1939

    Article  PubMed  Google Scholar 

  29. Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG (2005) Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 165(1):68–74

    Article  PubMed  Google Scholar 

  30. Fu AZ, Jiang JZ, Reeves JH, Fincham JE, Liu GG, Perri M 3rd (2007) Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care 45(5):472–476

    Article  PubMed  Google Scholar 

  31. Jano E, Aparasu RR (2007) Healthcare outcomes associated with beers’ criteria: a systematic review. Ann Pharmacother 41(3):438–447

    Article  PubMed  Google Scholar 

  32. Fick DM, Mion LC, Beers MH, Waller JL (2008) Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health 31(1):42–51

    Article  PubMed  Google Scholar 

  33. Bongue B, Laroche ML, Gutton S, Colvez A, Guéguen R, Moulin JJ et al (2011) Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system. Eur J Clin Pharmacol 67(12):1291–1299

    Article  PubMed  CAS  Google Scholar 

  34. Lindblad CI, Artz MB, Pieper CF, Sloane RJ, Hajjar ER, Ruby CM et al (2005) Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother 39(3):412–417

    Article  PubMed  Google Scholar 

  35. Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC et al (2004) Identification of serious drug-drug interactions: results of partnership to prevent drug–drug interactions. J Am Pharm Assoc 44(2):142–151

    Article  Google Scholar 

  36. Hanlon JT, Schmader ES (2005) Editorial. Drug–drug interactions in older adults—which ones matter ? Am J Geriatr Pharmacother 3(2):61–63

    Article  PubMed  Google Scholar 

  37. Becker LC (1978) Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 57(6):1103–1110

    Article  PubMed  CAS  Google Scholar 

  38. Vonkeman HE, van de Laar MA (2010) Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum 39(4):294–312

    Article  PubMed  CAS  Google Scholar 

  39. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM et al (2010) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. Br Med J 342:c7086. doi:10.1136/bmj.c7086

    Article  Google Scholar 

  40. Mintzer J, Burns A (2000) Anticholinergic side-effects of drugs in elderly people. J R Soc Med 93(9):457–462

    PubMed  CAS  Google Scholar 

  41. Kostis JB, Rosen RC, Holzer BC, Randolph C, Taska LS, Miller MH (1990) CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males. Psychopharmacology (Berl) 102(2):163–170

    Article  CAS  Google Scholar 

  42. Prichard BN, Graham BR (2000) I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly. Drugs Aging 17(2):133–159

    Article  PubMed  CAS  Google Scholar 

  43. Einhorn PT, Davis BR, Massie BM, Cushman WC, Piller LB, Simpson LM, ALLHAT Collaborative Research Group et al (2007) The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis. Am Heart J 153(1):42–53

    Article  PubMed  CAS  Google Scholar 

  44. Cipriani A, Barbui C, Brambilla P, Furukawa TA, Hotopf M, Geddes JR (2006) Are all antidepressants really the same? The case of fluoxetine: a systematic review. J Clin Psychiatry 67(6):850–864

    Article  PubMed  CAS  Google Scholar 

  45. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237

    Article  PubMed  CAS  Google Scholar 

  46. Coceani M, Mariotti R (2006) Is amiodarone safe in heart failure? Br Med J 332:317–318

    Article  Google Scholar 

  47. Zimetbaum P (2007) Amiodarone for atrial fibrillation. N Engl J Med 356(9):935–941

    Article  PubMed  CAS  Google Scholar 

  48. Foley P, Kalra P, Andrews N (2008) Amiodarone—avoid the danger of torsade de pointes. Resuscitation 76(1):137–141

    Article  PubMed  CAS  Google Scholar 

  49. Wyse DG (2009) Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation. J Interv Card Electrophysiol 25(1):25–29

    Article  PubMed  Google Scholar 

  50. European Medicines Agency (2007) European Medicines Agency recommends restricted use for piroxicam. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2009/11/WC500012655.pdf. Accessed 1 Oct 2011

  51. Gulmez SE, Droz-Perroteau C, Lassalle R, Blin P, Bégaud B, Rossignol M et al (2011) Are traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohort. Eur J Clin Pharmacol 67(8):833–838

    Article  PubMed  Google Scholar 

  52. Agency for Medicinal Products and Medical devices of Croatia. (2010) Annual report on drug consumption for 2009. Available at http://www.almp.hr/?ln=hr&w=publikacije&d=promet_lijekova_2009. Accessed 1 Oct 2011

  53. Veitch PC, Clifton-Bligh RJ (2004) Long-acting sulfonylureas—long-acting hypoglycaemia. Med J Aust 180(2):84–85

    PubMed  Google Scholar 

  54. Greco D, Angileri G (2004) Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older. Diabetes Nutr Metab 17(1):23–26

    PubMed  CAS  Google Scholar 

  55. Spagnoli A, Tognoni G (1983) ‘Cerebroactive’ drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders. Drugs 26(1):44–69

    Article  PubMed  CAS  Google Scholar 

  56. Frampton JE, Brogden RN (1995) Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders. Drugs Aging 7(6):480–503

    Article  PubMed  CAS  Google Scholar 

  57. Hoyer S (1995) Possibilities and limits of therapy of cognition disorders in the elderly. Z Gerontol Geriatr 28(6):457–462

    PubMed  CAS  Google Scholar 

  58. Teive HA, Troiano AR, Germiniani FM, Werneck LC (2004) Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord 10(4):243–245

    Article  PubMed  Google Scholar 

  59. No authors listed (2010) Haemorrhage due to Ginkgo biloba? Prescrire Int 17(93):19

    Google Scholar 

  60. Electronic Medicines Compendium. Available at: http://www.medicines.org.uk/EMC/medicine/2571/SPC/Serc-8mg/ Accessed 1 Oct 2011

  61. Andrus MR, Holloway KP (2004) Clark DB (2004) Use of beta-blockers in patients with COPD. Ann Pharmacother 38(1):142–145

    Article  PubMed  CAS  Google Scholar 

  62. Verdoux H, Lagnaoui R, Begaud B (2005) Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 35(3):307–315

    Article  PubMed  Google Scholar 

  63. Kotlyar M, Dysken M, Adson DE (2005) Update on drug-induced depression in the elderly. Am J Geriatr Pharmacother 3(4):288–300

    Article  PubMed  CAS  Google Scholar 

  64. Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkälä KH (2007) Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry 15(5):416–424

    Article  PubMed  Google Scholar 

  65. Weiden PJ (2007) EPS profiles: the atypical antipsychotics are not all the same. J Psychiatr Pract 13(1):13–24

    Article  PubMed  Google Scholar 

  66. Kamble P, Chen H, Sherer J, Aparasu RR (2008) Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother 6(4):187–197

    Article  PubMed  Google Scholar 

  67. Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B et al (2011) Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA 306(12):1359–1369

    Article  PubMed  CAS  Google Scholar 

  68. Larsson V, Engedal K, Aarsland D, Wattmo C, Minthon L, Londos E (2011) Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson’s disease dementia. Dement Geriatr Cogn Disord 32(4):227–234

    Article  PubMed  CAS  Google Scholar 

  69. Wu CS, Ting TT, Wang SC, Chang IS, Lin KM (2011) Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry 19(2):151–159

    Article  PubMed  Google Scholar 

  70. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 329(7456):15–19

    Article  Google Scholar 

  71. Huic M, Macolic V, Vrhovac B, Francetic I, Bakran I, Giljanovic S (1994) Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol Ther 32(12):675–682

    PubMed  CAS  Google Scholar 

  72. Franceschi M, Scarcelli C, Niro V, Seripa D, Pazienza AM, Pepe G et al (2008) Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 31(6):545–556

    Article  PubMed  Google Scholar 

  73. European Medicines Agency (2010) European Medicines Agency recommends suspension of marketing authorisations for sibutamine. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/01/WC500069995.pdf. Accessed 1 Oct 2011

  74. Baxter K (ed) (2005) Stockley’s drug interactions, 7th edn. Pharmaceutical Press, London

    Google Scholar 

  75. Dvir Y, Smallwood P (2008) Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry 30(3):284–287

    Article  PubMed  Google Scholar 

  76. Marot A, Morelle J, Chouinard VA, Jadoul M, Lambert M, Demoulin N (2011) Concomitant use of simvastatin and amiodarone resulting in severe rhabdomyolysis: a case report and review of the literature. Acta Clin Belg 66(2):134–136

    PubMed  CAS  Google Scholar 

  77. Laine L, Hennekens C (2010) Proton pump inhibitor and clopidogrel interaction: fact or fiction? Am J Gastroenterol 105(1):34–41

    Article  PubMed  CAS  Google Scholar 

  78. Siller-Matula JM, Jilma B, Schrör K, Christ G, Huber K (2010) Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb Haemost 8(12):2624–2641

    Article  PubMed  CAS  Google Scholar 

  79. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C et al (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370(9582):173–184

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacology Unit, University Hospital Center Osijek, Osijek, Croatia

    Suzana Mimica Matanović

  2. Department of Pharmacology, Medical School Osijek, University J.J. Strossmayer Osijek, Osijek, Croatia

    Suzana Mimica Matanović

  3. Clinical Pharmacology Unit, University Hospital Center Rijeka, Rijeka, Croatia

    Vera Vlahovic-Palcevski

Authors
  1. Suzana Mimica Matanović
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vera Vlahovic-Palcevski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suzana Mimica Matanović.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mimica Matanović, S., Vlahovic-Palcevski, V. Potentially inappropriate medications in the elderly: a comprehensive protocol. Eur J Clin Pharmacol 68, 1123–1138 (2012). https://doi.org/10.1007/s00228-012-1238-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-012-1238-1

Keywords

Search

Navigation